BioHarvest Sciences Inc. (BHST)

Market Cap	105.73M
Revenue (ttm)	22.43M
Net Income (ttm)	-17.19M
Shares Out	17.33M
EPS (ttm)	-1.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,562
Open	6.11
Previous Close	6.16
Day's Range	6.10 - 6.29
52-Week Range	0.00 - 7.38
Beta	n/a
Analysts	Strong Buy
Price Target	13.00 (+106.68%)
Earnings Date	Feb 15, 2025

About BHST

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness produc...

• Founded: 2007
• Country: Canada
• Stock Exchange: NASDAQ
• Ticker Symbol: BHST
• Website: https://www.bioharvest.com

Financial Performance

In 2023, BioHarvest Sciences's revenue was $12.67 million, an increase of 130.48% compared to the previous year's $5.50 million. Losses were -$12.56 million, 11.8% more than in 2022.

Financial numbers in USD

Analyst Forecast

According to 2 analysts, the average rating for BHST stock is "Strong Buy." The 12-month stock price forecast is $13.0, which is an increase of 106.68% from the latest price.

Price Target

$13.0

(106.68% upside)

Analyst Consensus: Strong Buy